• Kaisa Health Group Holdings will hold a special general meeting in Hong Kong on Sept. 1, 2026.
• Shareholders will vote on a proposal to change the company’s English name to Qinghai Biotech Pharmaceutical Group.
• The resolution also seeks to adopt “青海生物製藥集團有限公司” as the company’s Chinese secondary name, replacing the current one.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260812-12281759), on August 12, 2026, and is solely responsible for the information contained therein.